Czechia· CZ-0265022

RESELIGO

A goserelin product containing goserelin acetate, registered in Czechia by Zentiva, k.s., Praha. The same ATC class is registered in 12 of our 19 countries.

ATC L02AE03

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedRESELIGOATCL02AE03REGISTER NO.CZ-0265022PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Goserelin is registered in 12 of 19 countries.

Countries holding a registration under ATC L02AE03 (goserelin), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 8 of them publish a price we can compare per daily dose

Goserelin · ATC L02AE03

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of goserelin costs, country by country.

Normalised to the WHO defined daily dose (0.129 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Goserelin · price per daily dose (0.129 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$5.39
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Active substance
GOSERELIN ACETATE
Manufacturer
Zentiva, k.s., Praha
Country
Czechia (CZ)
ATC code
L02AE03
ATC class
Goserelin
Defined daily dose
0.129 mg, Implantat
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0265022
    1
    CZK 1375.4

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

461 interactions on record for goserelin.

Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Goserelin · interactions on record

461 records

  • 71 severe
  • 250 moderate
  • 3 minor
  • 137 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Goserelin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All goserelin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Zoladex Depot
  • Belgium · Zoladex, Zoladex Long Acting
  • Bulgaria · Золадекс, Золадекс Lа
  • Cyprus · Zoladex
  • Germany · Goserelin Endomedica, Gosgon
  • Denmark · Zoladex
  • Estonia · Reseligo, Zoladex
  • Spain · Zoladex, Zoladex Trimestral
  • Finland · Zoladex
  • France · Zoladex
  • United Kingdom (Northern Ireland) · Zoladex, Zoladex La
  • Greece · Implandex, Implandex La
  • Croatia · Reseligo, Zoladex
  • Hungary · Reseligo, Zildalis
  • Ireland · Zoladex, Zoladex La
  • Iceland · Reseligo, Zoladex
  • Italy · Zoladex
  • Lithuania · Algonad, Reseligo
  • Luxembourg · Zoladex, Zoladex Long Acting
  • Latvia · Reseligo
  • Malta · Golexin, Golexin La
  • Netherlands · Zoladex
  • Norway · Zoladex
  • Poland · Reseligo, Xanderla
  • Portugal · Golexin, Golexin La
  • Romania · Reseligo, Zoladex
  • Sweden · Zoladex
  • Slovenia · Reseligo, Zoladex
  • Slovakia · Reseligo, Zoladex Depot

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/564e8a48-0b10-464f-b7e6-a9e700e2f3c4
GET /v1/drugs/564e8a48-0b10-464f-b7e6-a9e700e2f3c4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "IMP ISP",
  "source": "sukl",
  "strength": "3,6MG",
  "pack_size": "1",
  "substance": "GOSERELIN ACETATE",
  "cz_kod_sukl": "0265022",
  "product_type": "CH",
  "substance_codes": "12077",
  "registration_state": "R",
  "registration_number": "56/107/16-C"
}

See everything about goserelin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.